News

FOCUS ON: Pharmacogenetics - Prediction of 5-Fluorouracil toxicity

26 November 2021

Focus On

The last FOCUS ON session for 2021 will take place Wednesday 15th December at 1pm GMT.

NEW: BRCA testing for Prostate Cancer - cfDNA EQA

15 November 2021

EQA Updates

GenQA, in collaboration with EMQN, are proud to announce the release of a new pilot EQA for prostate cancer testing using cfDNA in plasma.

Update on GenQA fees for 2022

10 November 2021

Other

Click here for the full statement.

FOCUS ON Acquired ISCN webinar now freely available

8 November 2021

Focus On

If you missed the webinar on 14th October, it is now available on the GenQA YouTube channel (https://www.youtube.com/genqa)

Tissue-i webinar for Ovarian tumours

5 November 2021

Individual Competency Updates

GenQA are proud to anounce a series of webinars providing expert discussion on previous Tissue-i cases. The second webinar one is on 3rd December at 2pm GMT.

Abbott/Vysis CLL Probe Recall

21 October 2021

Other

Please see following information regarding urgent recall of Abbott/Vysis CLL probe recall.

Latest Publication

11 October 2021

Other

GenQA's Dr Ros Hastings is an author on this latest publication: HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions.

2022 EQA Directory and Timetable published

22 September 2021

EQA Updates

The complete 2022 EQA Directory and timetable for April 2022 - March 2023 is now available.

2022 EQAs now open for enrolment

14 September 2021

EQA Updates

The GenQA 2022 EQAs are now open for enrolment! For the full list of EQAs go to www.genqa.org/eqa

Webinar available for 2020 EQA for Molecular Testing of BRCA and other HRR Gene Variants in Ovarian and Prostate Cancer

10 August 2021

EQA Updates

If you missed this webinar - its now available on the GenQA YouTube channel at (https://www.youtube.com/genqa)

Webinars for BRCA variant assessment (Run 6)

9 August 2021

Individual Competency Updates

The webinars for 'Ensuring Accurate Classification of variants in BRCA1 and BRCA2' are now freely available.

Survey report for CF and MCADD molecular newborn screening EQAs

9 August 2021

Engagement

GenQA surveyed the participants of the MCADD and CF molecular newborn screening EQAs regarding the quality of material provided and frequency of distributions.

National Genomic Test Directory EQA providers

7 April 2021

Other

GenQA are delighted to be one of the UK NEQAS External Quality Assessment providers for the National Genomic Test Directory (2021-2023)

GenQA Accreditation

8 February 2021

Engagement

Update on GenQA accreditation status